Alar Pharmaceuticals, Inc.

Taïwan, Province de Chine

 
Quantité totale PI 6
Rang # Quantité totale PI 260 596
Note d'activité PI 1,5/5.0    6
Rang # Activité PI 158 419

Brevets

Marques

6 0
0 0
0 0
0
 
Dernier brevet 2024 - Long-acting injectable formulati...
Premier brevet 2017 - Sustained-release buprenorphine ...

Derniers inventions, produits et services

2022 Invention Long-acting injectable formulations and crystalline forms of buprenorphine derivatives. This dis...
2020 Invention Long-acting injectable formulations of ketamine pamoate salts. Provided are sustained-release ph...
Invention Ketamine pamoate and use thereof. Provided are pamoate salts of ketamine having a stoichiometry o...
2019 Invention Naltrexone injectable sustained release formulation. Provided is an injectable sustained release ...
Invention Long-acting injectable formulations and crystalline forms of buprenorphine derivatives. This disc...
2017 Invention Sustained-release buprenorphine formulations. An injectable pharmaceutical composition includes a...